Key result
Extended prasugrel and clopidogrel therapy were evaluated for measured platelet function and cardiovascular outcomes in patients with ACS treated without revascularization.
Answers are grounded in this paper and cite their sources.
Extended prasugrel/clopidogrel evaluation in non-revascularized ACS should not change practice; leaves open optimal duration and platelet-guided strategies.
Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization: The TRILOGY ACS Platelet Function Substudy
No takes yet. Share an insight, caveat, or question.
Matthew J. Price (2012) studied this question. Extended prasugrel and clopidogrel therapy were evaluated for measured platelet function and cardiovascular outcomes in patients with ACS treated without revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: